GetPortalImpactFactorByIdResp(projectId=1, id=a7ec12294, cover=https://img.medsci.cn/images/journal/cover/2021/qND_202109271316068350.jpg, fullname=Molecular Therapy-Nucleic Acids, abbr=MOL THER-NUCL ACIDS, pyear=暂无数据, frequence=Monthly, articleNumbers=1600, citedSelf2015=7.2, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均4.27月, reviewFee=null, pageFee=3900.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2162-2531, greenSci=https://www.greensci.net/search?kw=2162-2531, scijournal=https://www.scijournal.org/impact-factor-of-MOL-THER-NUCL-ACIDS.shtml, medsciHotlightString=null, medsciHotlightRealtime=9.683, medsciHotlight=24.343, medsciHotlight5year=19.1518, citescore=0.0, hIndex=59, impactFactor=8.8, orgnization=Cell Press, orgnizationUrl=https://www.sciencedirect.com/, country=United States, countryCn=美国, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded|BIOSIS Previews, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.cell.com/molecular-therapy-family/nucleic-acids, websiteHits=9909, guideForAuthor=null, guideForAuthorHits=30, submitWebsite=https://mtna.msubmit.net/, submitWebsiteHits=6006, content=<p><em style="color: #2e2e2e;">Molecular Therapy Nucleic Acids</em><span style="color: #2e2e2e;"> is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents such as CRISPR/Cas9 and related technologies, pre-clinical target and biomarker validation, safety/efficacy studies, and clinical trials. </span><em style="color: #2e2e2e;">Molecular Therapy Nucleic Acids</em><span style="color: #2e2e2e;"> Other key topics include: Applications of DNA-based oligonucleotides and their derivatives Gene vectors for delivery of RNA-based therapies Development of nanoparticles and other delivery agents siRNAs, shRNAs, saRNAs, and miRNAs Aptamers, ribozymes, and DNAzymes Peptide nucleic acids Gene-modifying technology and applications, including gene editing, base editing, and related approaches ncRNAs as therapeutic targets and biomarkers Development of new nucleic acid chemistries for altering gene expression Mechanisms of gene and nucleic acid transfer/transfection Vector trafficking and biodistribution Bioinformatic analyses</span></p>, totalCites=14084, brief=MOL THER-NUCL ACIDS杂志医学行业，暂不明确子行业的级别不明杂志, articleType=论著为主，其它类型文章约占5-10%, medsciHeat=黑红, medsciComment=MOL THER-NUCL ACIDS在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=a7ec12294'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=13482, tagName=RNA, createdHits=6), ImpactFactorTagDto(id=803, tagName=Cancer, createdHits=5), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=4), ImpactFactorTagDto(id=2005, tagName=细胞生物学, createdHits=3), ImpactFactorTagDto(id=614, tagName=神经, createdHits=3), ImpactFactorTagDto(id=57728, tagName=分子治疗, createdHits=2), ImpactFactorTagDto(id=43441, tagName=nanoparticle, createdHits=2), ImpactFactorTagDto(id=4352, tagName=RNA结合蛋白, createdHits=2), ImpactFactorTagDto(id=65781, tagName=心肌保存, createdHits=1), ImpactFactorTagDto(id=1844, tagName=siRNA, createdHits=1), ImpactFactorTagDto(id=25095, tagName=核酸药物, createdHits=1), ImpactFactorTagDto(id=3794, tagName=生物材料, createdHits=1), ImpactFactorTagDto(id=72, tagName=呼吸, createdHits=1), ImpactFactorTagDto(id=77459, tagName=线粒体稳态, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=5.89), GetImpactFactorCiteScoreListResponse(year=2017, citescore=5.55), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.81), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.7), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=27.381), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=31.534), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=16.245), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=10.257), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=9.683)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Drug Discovery , rank=7/146), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=16/165)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2162-2531[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=MOLECULAR THERAPY-NUCLEIC ACIDS[ta], article_number=349, article_number_cn=116, earlyWarning=中科院预警：高风险（2021）, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)